Description
Tecentriq (atezolizumab) is a prescription monoclonal antibody made by Genentech, Inc., given intravenously to treat certain cancers. It works by blocking PD-1 receptors to help the immune system fight tumors. Available as a 1200 mg/20 mL solution in single-use vials. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Atezolizumab | HTML | Access the FDA dataset for Atezolizumab — ANDA 761347 submitted by Mylan Institutional LLC | Open resource |